Aurora Cannabis (TSE:ACB) Sets New 1-Year High at $6.74

Aurora Cannabis Inc. (TSE:ACB)’s stock price hit a new 52-week high on Thursday . The stock traded as high as C$6.74 and last traded at C$6.49, with a volume of 1819661 shares traded. The stock had previously closed at C$6.44.

Analyst Upgrades and Downgrades

Several analysts have recently commented on ACB shares. Canaccord Genuity Group raised shares of Aurora Cannabis from a “hold” rating to a “buy” rating and set a C$0.80 price objective on the stock in a report on Friday, February 9th. Jefferies Financial Group cut their price target on Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating on the stock in a research report on Tuesday, February 27th. Finally, CIBC decreased their price objective on Aurora Cannabis to C$6.00 and set a “neutral” rating for the company in a report on Wednesday, February 21st.

Aurora Cannabis Price Performance

The stock has a market capitalization of C$323.42 million, a price-to-earnings ratio of -0.08 and a beta of 2.83. The company has a current ratio of 3.79, a quick ratio of 2.48 and a debt-to-equity ratio of 18.51. The stock has a 50-day moving average price of C$2.75 and a 200 day moving average price of C$1.43.

Aurora Cannabis (TSE:ACB) last issued its quarterly earnings data on Thursday, February 8th. The company reported C($0.20) EPS for the quarter, missing the consensus estimate of C($0.10) by C($0.10). Aurora Cannabis had a net margin of 151.71% and a negative return on equity of 137.28%. The business had revenue of C$72.61 million during the quarter, compared to analyst estimates of C$63.50 million. As a group, equities research analysts expect that Aurora Cannabis Inc. will post -0.22 earnings per share for the current year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.